ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Nisy E. Ipe
Nuclear Technology | Volume 168 | Number 2 | November 2009 | Pages 559-563
Shielding Materials | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 2) / Radiation Protection | doi.org/10.13182/NT09-A9243
Articles are hosted by Taylor and Francis Online.
A typical particle therapy facility consists of an injector, a cyclotron or a synchrotron, a high-energy transport beam line, several treatment rooms including fixed-beam and gantry rooms, and even a research area. During the operation of these facilities, radiation is produced with neutrons being the dominant component outside the shielding. These facilities have large amounts of shielding with concrete thicknesses ranging up to [approximately]5 m or more. Space required for shielding can be minimized by using composite shielding or high-density material such as Ledite® (manufactured by Atomic International, Frederick, Pennsylvania). Transmission data for radiation from protons and carbon ions incident on tissue targets with energies in the therapeutic energy range of interest were derived using the Monte Carlo code FLUKA for three different compositions of Ledite. Use of Ledite® or composite shielding results in space savings when compared to concrete.